Stock listing
NASDAQ:MYOK MyoKardia Inc Stock
Follow MyoKardia Inc into a list and get an email when it puts out news.
Last close · NASDAQ:MYOK
$224.91 USD
Close on Nov 18, 2020 · No longer trades
- Lowest – highest close
- $6.73 – $224.91 USDSince Oct 28, 2015 · lowest Feb 16, 2016 · highest Nov 16, 2020
Delisted NASDAQ:MYOK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MYOK
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
MyoKardia Inc on 6ix
- Decks
- 4 decks · latest May 11, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (May 2020) | Corporate update | 20 slides | May 11, 2020 |
| Investor Presentation (March 2017) | Investor deck | 39 slides | Mar 6, 2017 |
| Technical Presentation (July 2016) | Technical | 10 slides | Jul 11, 2016 |
| Investor Presentation (March 2016) | Investor deck | 28 slides | Mar 8, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kimberly Popovits Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Rhythm Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2026); EXACT Sciences Corporation (Director · Since at least Jan 2, 2025); 10x Genomics, Inc. (Director · Since at least Mar 26, 2020); Kiniksa Pharmaceuticals International, plc (Director · Since at least May 23, 2018); Talis Biomedical Corp (Director · Feb 11, 2021 – Jun 9, 2023 · Past); Genomic Health Inc (President and CEO, Director · Nov 3, 2016 – Nov 8, 2019 · Past) | Director · Mar 15, 2017 – Nov 17, 2020 · Past |
| David Meeker Other companies: Kardigan, Inc. (Board of Directors · Since at least Jun 17, 2026); Pharvaris N.V. (Chair of the Board · Since at least Mar 18, 2026); Trevi Therapeutics, Inc. (Chairman · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Chairman, President, and Chief Executive Officer · Since at least Oct 4, 2017); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Savient Pharmaceuticals Inc (Director · Jan 7, 2013 – Jan 7, 2013 · Past) | Director · Apr 17, 2017 – Nov 17, 2020 · Past |
| Kevin P Starr Other companies: Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Aug 17, 2015 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Jun 15, 2023 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Sep 24, 2015 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Feb 19, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2017 · Past); Human Genome Sciences Inc (Director · May 3, 2007 – Jul 10, 2007 · Past) | Director · Oct 28, 2015 – Mar 7, 2018 · Past |
| Sunil Agarwal Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2024); Arvinas, Inc. (Director · Since at least Jun 15, 2023); Sana Biotechnology, Inc. (EVP, Head of Development & CMO · Feb 3, 2021 – Mar 3, 2022 · Past); Juno Therapeutics Inc (President of R & D · Apr 13, 2017 – Mar 5, 2018 · Past); Calithera Biosciences, Inc. (Director · Sep 29, 2015 – Jun 1, 2022 · Past); Ultragenyx Pharmaceutical Inc. (Chief Medical Officer · Aug 19, 2015 – Aug 19, 2016 · Past) | Director · Mar 4, 2016 – Nov 17, 2020 · Past |
| William C. Fairey Other companies: Ascendis Pharma A/S (Director · Since at least Mar 18, 2026); KalVista Pharmaceuticals, Inc. (Director · Since at least Apr 18, 2024); Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Mirum Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2021); ChemoCentryx Inc. (Chief Operating Officer · Jan 3, 2018 – Jan 3, 2018 · Past) | EVP, Chief Commercial Officer · Jan 28, 2019 – Nov 17, 2020 · Past |
| Mary B. Cranston Other companies: TPG Inc. (Director · Since at least Jan 13, 2022); Chemours Company (the) (Director · Since at least Apr 29, 2021); Visa Inc. (Director · Dec 11, 2020 – Jan 24, 2023 · Past); McAfee Inc (Director · Oct 22, 2020 – Mar 1, 2022 · Past) | Director · Jun 29, 2020 – Nov 17, 2020 · Past |
| Bob McDowell Other companies: Kardigan, Inc. (Co-Founder and Scientific Adviser · Since at least Nov 5, 2026); Sunesis Pharmaceuticals Inc (Vice President, Research · Sep 11, 2007 – Sep 13, 2007 · Past) | Chief Scientific Officer · Oct 28, 2015 – Nov 17, 2020 · Past |
| Jonathan C. Fox Other companies: Edgewise Therapeutics, Inc. (Director · Since at least Mar 2, 2023); Eidos Therapeutics Inc (See Remarks · Jun 19, 2018 – Jan 26, 2021 · Past) | Chief Medical Officer · Oct 28, 2015 – Apr 29, 2016 · Past |
| Marc Semigran Other companies: Edgewise Therapeutics, Inc. (Chief Development Officer · Dec 19, 2022 – Dec 24, 2024 · Past); ProKidney Corp. (Director · Jun 29, 2021 – Jun 29, 2021 · Past) | Chief Medical Officer · Dec 1, 2016 – Feb 8, 2019 · Past |
| Mark L Perry Other companies: Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Oct 5, 2022 · Past); NVIDIA Corporation (Director · May 20, 2010 – Jun 26, 2024 · Past) | Director · Oct 28, 2015 – Nov 17, 2020 · Past |
All 13 people
| Person | Seat |
|---|---|
| Anastasios Gianakakos Other companies: Kardigan, Inc. (President & CEO, Director · Since at least Jun 17, 2026) | President and CEO, Director · Oct 28, 2015 – Nov 17, 2020 · Past |
| Denelle J Waynick Other companies: Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past) | Chief Legal Officer · Jun 29, 2020 – Nov 17, 2020 · Past |
| Joseph Lambing | See Remarks · Oct 28, 2015 – Feb 8, 2019 · Past |
Log in to ask 6ix AI your own questions about MyoKardia Inc.